News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,719 Results
Type
Article (3643)
Company Profile (28)
Press Release (43048)
Section
Business (14296)
Career Advice (58)
Deals (1804)
Drug Delivery (7)
Drug Development (3844)
Employer Resources (3)
FDA (585)
Job Trends (1280)
News (20148)
Policy (1355)
Tag
Academia (428)
Accelerated approval (4)
Allergies (3)
Alliances (5620)
ALS (13)
Alzheimer's disease (82)
Antibody-drug conjugate (ADC) (13)
Approvals (599)
Artificial intelligence (82)
Autoimmune disease (6)
Automation (11)
Bankruptcy (14)
Best Places to Work (1126)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (24)
Bladder cancer (12)
Brain cancer (7)
Breast cancer (107)
Cancer (591)
Cardiovascular disease (15)
Career advice (58)
Career pathing (2)
CAR-T (25)
Celiac Disease (1)
Cell therapy (83)
Cervical cancer (1)
Clinical research (2832)
Collaboration (232)
Compensation (23)
Complete response letters (2)
COVID-19 (205)
CRISPR (42)
C-suite (62)
Cystic fibrosis (9)
Data (481)
Depression (2)
Diabetes (22)
Diagnostics (1478)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (23)
Drug pricing (2)
Duchenne muscular dystrophy (13)
Earnings (3628)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (6849)
Executive appointments (85)
FDA (720)
Friedreich's ataxia (1)
Funding (101)
Gene editing (97)
Generative AI (5)
Gene therapy (92)
GLP-1 (37)
Government (296)
Guidances (23)
Healthcare (1280)
HIV (3)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (3)
Immuno-oncology (6)
Indications (8)
Infectious disease (219)
Inflammatory bowel disease (11)
Influenza (7)
Intellectual property (13)
Interviews (4)
IPO (793)
Job creations (185)
Job search strategy (54)
JPM (3)
Labor market (3)
Layoffs (18)
Legal (213)
Liver cancer (9)
Longevity (2)
Lung cancer (102)
Lymphoma (24)
Machine learning (8)
Management (1)
Manufacturing (47)
MASH (5)
Medical device (345)
Medtech (347)
Mergers & acquisitions (1068)
Metabolic disorders (38)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (21)
Neuropsychiatric disorders (1)
Neuroscience (143)
NextGen: Class of 2026 (399)
Non-profit (301)
Now hiring (4)
Obesity (9)
Opinion (30)
Ovarian cancer (7)
Pain (12)
Pancreatic cancer (24)
Parkinson's disease (15)
Partnered (2)
Patents (22)
Patient recruitment (19)
Peanut (1)
People (4668)
Pharmaceutical (2)
Phase 1 (1257)
Phase 2 (1357)
Phase 3 (844)
Pipeline (308)
Policy (19)
Postmarket research (37)
Preclinical (704)
Press Release (22)
Prostate cancer (22)
Radiopharmaceuticals (6)
Rare diseases (82)
Real estate (359)
Regulatory (1048)
Reports (3)
Research institute (524)
Resumes & cover letters (3)
Rett syndrome (6)
RSV (2)
Schizophrenia (4)
Series A (22)
Series B (14)
Sickle cell disease (24)
Spinal muscular atrophy (4)
Sponsored (2)
Startups (363)
Supply chain (6)
Vaccines (30)
Venture capital (4)
Weight loss (4)
Date
Today (9)
Last 7 days (32)
Last 30 days (128)
Last 365 days (1862)
2026 (193)
2025 (1928)
2024 (2839)
2023 (3361)
2022 (4460)
2021 (4675)
2020 (3933)
2019 (3008)
2018 (2251)
2017 (2529)
2016 (2422)
2015 (2504)
2014 (1609)
2013 (1387)
2012 (1415)
2011 (1409)
2010 (1237)
Location
Africa (60)
Alabama (9)
Alaska (1)
Arizona (22)
Asia (2420)
Australia (361)
California (1034)
Canada (133)
China (72)
Colorado (23)
Connecticut (48)
Delaware (12)
Europe (5974)
Florida (97)
Georgia (4)
Hawaii (2)
Idaho (1)
Illinois (33)
India (4)
Indiana (12)
Iowa (8)
Japan (31)
Kansas (4)
Kentucky (2)
Louisiana (3)
Maine (4)
Maryland (112)
Massachusetts (637)
Michigan (14)
Minnesota (31)
Mississippi (1)
Missouri (10)
Montana (2)
Nebraska (5)
Nevada (6)
New Hampshire (3)
New Jersey (134)
New Mexico (11)
New York (155)
North Carolina (170)
North Dakota (7)
Northern California (481)
Ohio (22)
Oregon (3)
Pennsylvania (78)
Rhode Island (3)
South America (61)
South Carolina (3)
Southern California (408)
Tennessee (5)
Texas (203)
United States (2957)
Utah (37)
Virginia (11)
Washington D.C. (4)
Washington State (53)
Wisconsin (23)
46,719 Results for "verge genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635
Verge Genomics and Ferrer have announced a strategic collaboration to co-develop VRG50635, Verge’s lead drug candidate, for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis, in Europe, Central and South America, Southeast Asia, and Japan.
March 25, 2024
·
4 min read
Biotech Bay
Verge Genomics to Present at Evercore ISI 2024 Emerging Biotech Conference
Verge Genomics announced today that Verge Co-founder and CEO Alice Zhang will present at the virtual Evercore ISI 2024 Emerging Biotech Conference, on Wednesday, February 28th from 10:45 a.m. – 11:15 a.m. EST.
February 21, 2024
·
1 min read
Biotech Bay
Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Verge Genomics announced that Verge Genomics’ co-founder and CEO, Alice Zhang, will present at the 42nd Annual J.P. Morgan Healthcare Conference.
January 3, 2024
·
1 min read
Business
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
Stem Pharm, Inc. and Verge Genomics, announced a collaboration to develop a disease model to validate novel targets identified by Verge for Parkinson’s disease (PD).
October 10, 2023
·
3 min read
Biotech Bay
Verge Genomics and the Pritzker Neuropsychiatric Disorders Research Consortium Form Cutting Edge Schizophrenia Research CollaborationResearch to analyze data from schizophrenia patient brain tissue with Verge’s AI-powered platform
Verge Genomics announced that it has entered into a collaboration with the Pritzker Neuropsychiatric Disorders Research Consortium to further the company’s cutting-edge research on schizophrenia.
October 31, 2023
·
3 min read
Press Releases
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
November 20, 2024
·
3 min read
Press Releases
Verge Genomics Announces New Development Candidate, VRG201, a Novel Maintenance Therapy for Long-Term Weight Management
December 16, 2024
·
3 min read
Press Releases
Verge Genomics and Collaborators Identify Digital Clinical Biomarker Endpoints Sensitive to Short Term Disease Progression in the Pre-treatment Run-in Period of VRG50635 Proof-of-Concept ALS Clinical Trial
April 7, 2025
·
3 min read
Press Releases
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
January 9, 2026
·
2 min read
Drug Development
Verge Genomics Announces Initiation of Proof-of-Concept Study for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with VRG50635
Verge Genomics, a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, today announced the initiation of its Phase 1b proof-of-concept study of VRG50635 for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS).
January 9, 2024
·
4 min read
1 of 4,672
Next
